NVST Form 144: 15,000 Shares from Restricted Stock Vesting Proposed for Sale
Rhea-AI Filing Summary
Envista Holdings Corporation (NVST) filed a Form 144 proposing the sale of 15,000 common shares through Fidelity Brokerage Services with an aggregate market value of $324,000. The filing reports 166,181,720 shares outstanding and an approximate sale date of 08/25/2025 on the NYSE. The 15,000 shares match a series of restricted stock vesting events received as compensation between 02/24/2020 and 02/25/2024, shown as multiple vesting lots totaling 15,000 shares. The filer reports no securities sold in the past three months and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Positive
- Full disclosure of lot-level acquisition dates and amounts showing the 15,000 shares originated from compensation-related restricted stock vesting.
- Filing specifies broker, aggregate market value ($324,000), and planned sale date (08/25/2025), supporting transparency.
- Seller attests no undisclosed material adverse information, consistent with Rule 144 certification language.
Negative
- Planned insider sale of 15,000 shares could be perceived by some investors as a liquidity event for an insider.
Insights
TL;DR: Routine insider sale: 15,000 shares (about 0.009% of outstanding) from vested restricted stock, scheduled via broker on 08/25/2025.
The filing discloses a proposed sale of 15,000 common shares through Fidelity with an aggregate market value of $324,000. The shares were acquired solely through restricted stock vesting across 2020–2024 as compensation, and there were no reported sales in the past three months. For investors, this is a transparent, routine disclosure of an insider liquidity event; the size relative to total outstanding shares is immaterial based on figures provided.
TL;DR: Proper compliance: Form 144 documents planned sale and confirms seller's representation about material nonpublic information.
The form includes the standard attestation that the seller does not possess undisclosed material adverse information and lists the dates and amounts of restricted-stock vesting that created the shares to be sold. The filing shows compliance with Rule 144 notice requirements and provides clear broker, lot, and acquisition details, aiding transparency for shareholders and regulators.
AI-generated analysis. How Rhea-AI works. Not financial advice.